We restore endothelial cell function.
Welcome
Pantherna Therapeutics is a privately-held biopharmaceutical Company developing first-in-class therapeutics for vascular diseases. Pantherna’s innovative technology platform is based on advanced nanoparticles for the delivery and expression of therapeutic mRNA drugs in the endothelium.
Pantherna is based in Hennigsdorf (Brandenburg) close to Berlin, Germany.
Latest News
811, 2019
Pantherna Therapeutics to present at BIO-Europe 2019
Dr. Klaus Giese (CEO) will present in the Start-Up Slam at the BIO-Europe 2019 conference in Hamburg on Tuesday, Nov 12.
Team
Contact
Get in touch
Pantherna Therapeutics GmbH
Neuendorfstrasse 20b
D-16761 Hennigsdorf
Germany
Telephone: +49(0)3302-202 240-0
Telefax: +49(0)3302-202 240-1
E-Mail: contact@pantherna-therapeutics.com
Managing Directors: Dr. Klaus Giese, Dr. Jörg Kaufmann, Dr. Gerrit Maass
How can we help?
For privacy reasons Google Maps needs your permission to be loaded.
I AcceptPublic Funding
